Influenza Vaccination Digital Interventions for People Living With Diabetes

Diabetes Clinical Trial

Official title:

Influenza Vaccination Digital Interventions for People Living With Diabetes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03870997
• Other study ID #: EH-008
• Status: Completed
• Phase: N/A
• Start date: September 12, 2018
• Est. completion date: April 8, 2019

Study information

• Verified date: June 2020
• Source: Evidation Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The overall objective of this prospective randomized controlled study is to assess and quantify the impact of digital interventions to increase vaccination rates and vaccination-related outcomes in a connected population with self-reported diabetes. The digital intervention will be delivered via a campaign sent to participants, with interventions varying with each study arm. Participants will be blinded to study participation status.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 94321
• Est. completion date: April 8, 2019
• Est. primary completion date: April 8, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• At least 18 years old

• Lives in the U.S.

Exclusion Criteria:

• < 18 years old

• Does not live in the U.S.

Related Conditions & MeSH terms

• Diabetes
• Diabetes Mellitus

Intervention

Behavioral:
• Diabetes Digital Intervention
The Diabetes Digital Intervention is a digital campaign that provides interactive ways (e.g., videos, infographics, quizzes) for individuals to learn about influenza and related complications, and the importance of influenza vaccination. It is tailored to people living with diabetes and highlights the importance of influenza vaccination for this specific patient population.
• Generic Digital Intervention
The Generic Digital Intervention is a digital campaign that provides interactive ways (e.g., videos, infographics, quizzes) for individuals to learn about influenza and related complications, and the importance of influenza vaccination. It provides generic influenza vaccination interventions that can be applicable to any adult who should receive influenza vaccination.

Locations

Country	Name	City	State
United States	Evidation Health	San Mateo	California

Sponsors (2)

Lead Sponsor	Collaborator
Evidation Health	Sanofi Pasteur, a Sanofi Company

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Participants With Self-reported Influenza Vaccination in People With Diabetes	Number of participants with self-reported influenza vaccination in People With Diabetes: Intervention arm as compared to People With Diabetes: Control arm	6 months